Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis.
Karen S McCoyJill E BlindTerri JohnsonPatti OlsonLaura RatermanShasha BaiMariah EisnerShahid I SheikhStephan DruhanCody YoungKimberly PasleyPublished in: Pediatric pulmonology (2023)
, subjective reports of clinical status, level of activity, and a reduction in burden of treatment.